SutroVax announced the appointment of Elaine Sun as Chief Financial Officer and the additions of Peter Hirth, Ph.D., to the company's Board of Directors and Jeffrey Almond, PhD. FMedSci, to the Scientific Advisory Board. Prior to joiningSutroVax, Ms. Sun served as Managing Director and head of West Coast health care for Evercore Partners, where she led biotechnology coverage.

Prior to Evercore, Dr. Hirth co-founded and led Plexxikon, Inc. as its CEO as it built a novel, structure-guided drug discovery platform. Dr. Almond is Visiting Professor of Microbiology at the William Dunn School of Pathology, University of Oxford and is an Oxford Martin Fellow with the Oxford Martin Programme on Vaccines. Before that he was Vice President and Head of Discovery Research and External R&D at Sanofi Pasteur.